Article Text
Abstract
Objectives: This study was designed to explore the prevalence and types of stipulations (such as clarifications or changes) required of investigators by the institutional review board (IRB) of one institution over a five year period.
Design: Stipulations to research proposals (n = 124) were documented from the minutes of the IRB meetings.
Setting: Community hospital.
Participants: IRB submissions.
Main measurements: Number and type of IRB stipulations.
Results: Nineteen research submissions (15.3%) were approved without any stipulations. For the remainder, the majority of stipulations related to consent forms (74.2%).
Conclusions: Consent forms appear to be at highest risk for IRB stipulations. Being aware of high risk areas before submission of research proposals may reduce the frequency of stipulations required of investigators.
- IRB stipulations
- research submissions
- research
Statistics from Altmetric.com
Footnotes
Read the full text or download the PDF:
Other content recommended for you
- Clinical Research From Proposal to Implementation
- Can an ethics officer role reduce delays in research ethics approval? A mixed-method evaluation of an improvement project
- Understanding Food and Drug Administration Regulatory Requirements for an Investigational Device Exemption for Sponsor-Investigators
- Multicentre trials review process by research ethics committees in Spain: where do they stand before implementing the new European regulation?
- Analysis of warning letters issued by the US Food and Drug Administration to clinical investigators, institutional review boards and sponsors: a retrospective study
- 6ER-023 The role of institutional review boards, and hospital pharmacists as members, in the informed consent process in clinical research: a retrospective observational study
- SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
- Leveraging artificial intelligence to detect ethical concerns in medical research: a case study
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- A rationale and framework for seeking remote electronic or phone consent approval in endovascular stroke trials – special relevance in the COVID-19 environment and beyond